EXACT Sciences (NASDAQ:EXAS) will issue its quarterly earnings data after the market closes on Thursday, February 21st. Analysts expect the company to announce earnings of ($0.50) per share for the quarter.
EXACT Sciences stock opened at $89.27 on Thursday. EXACT Sciences has a 1-year low of $37.36 and a 1-year high of $90.94. The company has a debt-to-equity ratio of 0.94, a quick ratio of 11.72 and a current ratio of 12.08. The firm has a market capitalization of $11.03 billion, a price-to-earnings ratio of -90.17 and a beta of 1.83.
In other news, insider Kevin T. Conroy sold 304,397 shares of EXACT Sciences stock in a transaction dated Friday, January 25th. The stock was sold at an average price of $81.27, for a total transaction of $24,738,344.19. Following the sale, the insider now owns 1,190,408 shares in the company, valued at $96,744,458.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jeffrey Thomas Elliott sold 90,909 shares of EXACT Sciences stock in a transaction dated Thursday, January 24th. The stock was sold at an average price of $78.90, for a total value of $7,172,720.10. Following the sale, the chief financial officer now owns 124,120 shares in the company, valued at approximately $9,793,068. The disclosure for this sale can be found here. Insiders have sold 396,887 shares of company stock worth $32,010,272 in the last quarter. Insiders own 3.20% of the company’s stock.
EXACT Sciences Company Profile
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer.
Featured Article: Market Capitalization in the Stock Market
Receive News & Ratings for EXACT Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EXACT Sciences and related companies with MarketBeat.com's FREE daily email newsletter.